Immunovant Stock (NASDAQ:IMVT), Quotes and News Summary

Q: What sector and industry does Immunovant (IMVT) operate in?

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.

Open	$28.210
Close	-
Volume / Avg.	160.020K / 1.153M
Day Range	28.200 - 29.220
52 Wk Range	14.590 - 45.580
Market Cap	$4.174B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	12.9%
Days to Cover	6.93

Recent News

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Avi Kapoor

Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%

Immunovant Inc (NASDAQ: IMVT), on Thursday, released the results from the initial cohort of patients in an ongoing 24-week Phase 2 trial of batoclimab in

Vandana Singh

Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Nov 23

Dec 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Immunovant Inc

Sector

Health Care

Industry

Biotechnology

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunovant (IMVT) stock?

You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.

View our list of the best stock brokerages.

Who are Immunovant's (IMVT) competitors?

Other companies in Immunovant’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the target price for Immunovant (IMVT) stock?

The latest price target for Immunovant (NASDAQ: IMVT) was reported by Oppenheimer on Thursday, March 28, 2024. The analyst firm set a price target for 50.00 expecting IMVT to rise to within 12 months (a possible 74.03% upside). 35 analyst firms have reported ratings in the last year.

Current Stock Price for Immunovant (IMVT)?

The stock price for Immunovant (NASDAQ: IMVT) is $28.73 last updated Today at April 18, 2024 at 11:03 AM EDT.

Does Immunovant (IMVT) pay a dividend?

There are no upcoming dividends for Immunovant.

When is Immunovant (NASDAQ:IMVT) reporting earnings?

Immunovant’s Q4 earnings are confirmed for Monday, May 20, 2024.

Is Immunovant (IMVT) going to split?

There is no upcoming split for Immunovant.

What sector and industry does Immunovant (IMVT) operate in?

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-